Amgen's Revenues have nearly Doubled in the Last Three Years Rising to $10.55 billion in 2004.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c24499) has announced the addition of Amgen: Profile, Patents and Pipeline to their offering Amgen is the world's largest biotechnology company and the eighth largest pharmaceutical company worldwide. Revenues have nearly doubled in the last three years, going from $5.52 billion in 2002 to $10.55 billion in 2004. Yet the majority of revenue is based on twenty-year old technology. Can Amgen continue its amazing a·maze v. a·mazed, a·maz·ing, a·maz·es v.tr. 1. To affect with great wonder; astonish. See Synonyms at surprise. 2. Obsolete To bewilder; perplex. v.intr. revenue growth? Or will it fall behind, lacking the small molecule therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. that are the mainstay of modern pharmaceuticals? This report provides an in-depth analysis of Amgen's - Strategic strengths and weaknesses - Current therapeutic products and pipeline of future products - Financial analysis, including R& D productivity - Current patents and patent applications - Alliances, joint ventures and acquisitions - Key personnel Who should buy this report? - Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. and pharmaceutical companies of all sizes interested in understanding Amgen's rapid climb to success and its future direction - Early stage biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. interested in understanding Amgen Ventures strategy for investing its $100 million - Financial analysts looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. an in-depth technical analysis of Amgen's future revenue sources Key reasons to purchase this report - Competitive intelligence - Benchmark company performance against the leading biotechnology company - Understand what is driving Amgen's growth, and what is holding it back This 81 page up-to-date report, based on information gathered through the end of the first quarter 2005, contains five tables on Amgen's pipeline; a listing of the last three years of granted patents, analyzed an·a·lyze tr.v. an·a·lyzed, an·a·lyz·ing, an·a·lyz·es 1. To examine methodically by separating into parts and studying their interrelations. 2. Chemistry To make a chemical analysis of. 3. by therapeutic area as well as therapeutic form; a breakdown of sales for all key products; both U.S. and International, as well as a list of all patent applications for 2004 through the first quarter of 2005. Topics covered in the report: - Amgen Strategy - Key Events 2004 - Key Products - Drug Pipeline - Recent Clinical Trials Results - Joint Ventures and Collaborations - Recent Acquisitions - Manufacturing and Suppliers - Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and Contract Disputes - Amgen Financials - Amgen's US Patents For more information visit http://www.researchandmarkets.com/reports/c24499 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion